NeoGenomics, Inc.NEONASDAQ
Loading
EBITDA as a percentage of revenue
5Y CAGR
-50.2%/yr
Long-term compound
Percentile
P29
Within normal range
vs 5Y Ago
0x
Contraction
Streak
3 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.24% | +204.9% |
| 2024 | -0.23% | +92.3% |
| 2023 | -2.98% | +81.6% |
| 2022 | -16.15% | -19.6% |
| 2021 | -13.50% | -272.2% |
| 2020 | 7.84% | -14.8% |
| 2019 | 9.20% | -19.9% |
| 2018 | 11.49% | +3.9% |
| 2017 | 11.05% | +6.3% |
| 2016 | 10.39% | - |